The Pro-Chol Study
The ProChol Study - Prospective Assessment of Symptoms Following Cholecystectomy in Patients With Symptomatic Uncomplicated Gallstones
Nordsjaellands Hospital
800 participants
Jan 22, 2024
OBSERVATIONAL
Conditions
Summary
This prospective clinical cohort study will include patients with gallstones and abdominal pain scheduled for surgery (laparoscopic cholecystectomy). Data on quality of life, abdominal pain, gallstone disease, and patient characteristics will be collected before surgery. The outcomes will be assessed three months following surgery and will primarily be determinants for resolution of pain. The aim is to make a prediction score that may aid clinicians and patients in decision making about surgery.
Eligibility
Inclusion Criteria7
- Ultrasound examination with presence of gallstones and description of size, number and presence of stones in infundibulum or cystic duct
- Abdominal symptoms believed to be caused by symptomatic uncomplicated gallstones
- Indication and candidate for elective laparoscopic cholecystectomy
- Above 18 years of age
- Ability to give oral and written consent
- Ability to understand, speak and read Danish
- Ability to receive digital post
Exclusion Criteria5
- History of complicated gallstone disease including acute cholecystitis, pancreatitis, common bile duct stones, or cholangitis
- Previous sphincterotomy
- Abnormal liver function test (ALAT/ASAT, alkaline phosphatase, bilirubin) without magnetic resonance cholangio-pancreatography or endoscopic ultrasound to rule out common bile duct pathology
- Indication for urgent cholecystectomy
- Current pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A surgical removal of the gallbladder through laparoscopy
The intervention is intended laparoscopic cholecystectomy. Patients that undergo conversion to open (traditional) cholecystectomy will still be included. Patients scheduled for open cholecystectomy will not be included.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07245108